News Results for Stephan A. Grupp, MD, PhD

1 - 10 of 49

First Approved CAR T-Cell Therapy Shows Continued Benefits Five Years Later

Published on Jun 16, 2022 in Press Releases
New data show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.

New Data Show Benefits of CRISPR-edited Gene Therapy for Blood Disorders in Larger Patient Group with Longer-Term Follow-Up

Published on Jun 14, 2022 in Press Releases
A group of researchers that include CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.

In The News: Breastfeeding, Allogeneic CART, Costa Rica Partners, CPR Education, Cognitive Outcomes

Published on May 27, 2022 in Cornerstone Blog
In the News Learn about novel findings and notable achievements from our Children’s Hospital of Philadelphia researchers.

Penn Medicine and Children’s Hospital of Philadelphia Announce Partnership with Costa Rica for CAR T Cell Therapy

Published on May 23, 2022 in Press Releases
CHOP, Penn, Costa Rica: International collaboration aims to ensure more equitable access to transformative personalized cancer therapy

Emily Whitehead, 10 Years Later: Q&A With Stephan Grupp, MD, PhD

Published on May 11, 2022 in Cornerstone Blog
Emily Whitehead, 10 Years Later: Q&A With Stephan Grupp, MD, PhD In this Q&A, Stephan Grupp, MD, PhD, discusses his experience delivering CAR T-cell therapy to the first pediatric patient, Emily Whitehead.

CHOP Establishes the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy

Published on Mar 28, 2022 in Cornerstone Blog
New Center for Pediatric Cancer Immunotherapy The Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy is a first-of-its-kind hub for pediatric Cancer Immunotherapy.

In The News: Sequencing Bone Marrow DNA, Neonates, Greening Interventions, Beckwith-Wiedemann Spectrum

Published on Dec 10, 2021 in Cornerstone Blog
In the News Our research news highlights a study about sequencing bone marrow DNA after CAR T-cell therapy and how it accurately predicts leukemia relapse.

Study Finds Sequencing Bone Marrow DNA after CAR-T Can Accurately and Sensitively Predict Leukemia Relapse

Published on Dec 1, 2021 in Press Releases
Next-generation DNA sequencing can predict relapse of patients with acute lymphoblastic leukemia treated with (CAR) T-cell therapy.

In the News: Mental Health, Fontan Circulation, Social Impairment, Gene Therapy

Published on Aug 20, 2021 in Cornerstone Blog
In The News This week in the news, we share findings on Fontan circulation side effects, pediatric brain tumor survivorship, gene therapy, and more.

Scientific Symposium Gets to ‘Heart of Disease’ With Cell and Gene Therapy Talks

Published on May 26, 2021 in Cornerstone Blog
17th Scientific Symposium Gets to ‘Heart of Disease’ The 17th Research Institute Scientific Symposium, held virtually on May 20, highlighted advances in cell and gene therapy.
1 - 10 of 49